乘势越千帆|南京医药“双过半”冲刺战

南京医药股份有...2025-06-19

2025年上半年，面对复杂市场环境，南京医药上下牢固树立“一盘棋”意识，以高质量发展为核心，将经营指标逐层拆解至各省级平台、各业务业态，实现“人人头上有指标、个个肩上有担子”。01江苏业务中心江苏业务中心以“多维分解+数智驱动+协同作战”组合拳推动经营指标落地。江苏业务中心组织省平台经营策略研讨会，各企业围绕指标缺口寻求“破局”措施，形成“群策群力、资源共享”的冲刺氛围。此前，中心已召开两场...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2544165777?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-19 18:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2544165777","market":"sh","top_or_hot":-1,"title":"乘势越千帆|南京医药“双过半”冲刺战","media":"南京医药股份有...","content":"<div>\n<p>2025年上半年，面对复杂市场环境，南京医药上下牢固树立“一盘棋”意识，以高质量发展为核心，将经营指标逐层拆解至各省级平台、各业务业态，实现“人人头上有指标、个个肩上有担子”。01江苏业务中心江苏业务中心以“多维分解+数智驱动+协同作战”组合拳推动经营指标落地。江苏业务中心组织省平台经营策略研讨会，各企业围绕指标缺口寻求“破局”措施，形成“群策群力、资源共享”的冲刺氛围。此前，中心已召开两场...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619184223a7125d68&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>乘势越千帆|南京医药“双过半”冲刺战</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n乘势越千帆|南京医药“双过半”冲刺战\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-19 18:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619184223a7125d68&s=b><strong>南京医药股份有...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年上半年，面对复杂市场环境，南京医药上下牢固树立“一盘棋”意识，以高质量发展为核心，将经营指标逐层拆解至各省级平台、各业务业态，实现“人人头上有指标、个个肩上有担子”。01江苏业务中心江苏业务中心以“多维分解+数智驱动+协同作战”组合拳推动经营指标落地。江苏业务中心组织省平台经营策略研讨会，各企业围绕指标缺口寻求“破局”措施，形成“群策群力、资源共享”的冲刺氛围。此前，中心已召开两场...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619184223a7125d68&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0250","symbol_name":"批发","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619184223a7125d68&s=b","article_id":"2544165777","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619184223a7125d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2544165777","pubTimestamp":1750329353,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"03南药湖北南药湖北“日通报强执行，周复盘促提升”，全员冲刺倒计时。南药湖北全体员工正以昂扬的斗志、务实的作风，争分夺秒、奋力拼搏，向着胜利实现“时间过半、任务过半”的目标全力冲刺。当前，南京医药正以“时不我待”的紧迫感和“舍我其谁”的责任感，在冲刺“双过半”的赛道上奋勇前行，全体员工将继续发扬迎难而上的奋斗精神，以更昂扬的斗志和更高效的执行力，朝着既定发展目标稳步迈进。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600713":"南京医药","BK0250":"批发","BK0209":"零售"},"translate_title":"Taking advantage of the momentum and crossing thousands of sails, Nanjing Pharmaceutical's \"double half\" sprint battle","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600713":1},"content_text":"2025年上半年，面对复杂市场环境，南京医药上下牢固树立“一盘棋”意识，以高质量发展为核心，将经营指标逐层拆解至各省级平台、各业务业态，实现“人人头上有指标、个个肩上有担子”。01江苏业务中心江苏业务中心以“多维分解+数智驱动+协同作战”组合拳推动经营指标落地。江苏业务中心组织省平台经营策略研讨会，各企业围绕指标缺口寻求“破局”措施，形成“群策群力、资源共享”的冲刺氛围。此前，中心已召开两场专题会议，销售与采购团队精准对接品种保供方案，确保“冲刺不掉链”。中心以数智化手段打通业务全链条，建立“日日反馈、周周复盘”机制，通过数据看板实时追踪指标进度；针对基层市场，销售团队加密拜访频次；通过处方外流承接，加速院边药房、专业药房布局。在创新业务领域，医美、麻精、核药等新兴业态多点发力。02安徽天星安徽天星“亮灯预警+挂牌督战”紧盯指标进度，拼出发展加速度。面对市场挑战，公司全体员工发扬“钉钉子”精神，迎难而上，建立客户分级覆盖机制，加强项目动态管理。业务前线敏锐把握市场机遇，深度挖掘客户需求；职能中台持续优化流程，提升服务效率与响应速度；全员强化服务意识，凝聚起攻坚克难、协同作战的强大合力，月度经营例会亮灯预警滞后指标，季度考核挂钩预算达成率并挂牌督战，以医药铁军纪律拼出发展加速度。03南药湖北南药湖北“日通报强执行，周复盘促提升”，全员冲刺倒计时。围绕“稳销售、清回款、强准入、推项目、控风险”五项重点工作，公司内部处处涌动着“比学赶超、争创一流”的奋斗激情。从领导班子靠前指挥、精准施策，到一线业务员奔波于客户之间；从物流中心灯火通明高效运转，到后台职能部门全力做好支持保障；从每日通报业绩指标到每周复盘分析，各部都铆足干劲、奋发拼搏。南药湖北全体员工正以昂扬的斗志、务实的作风，争分夺秒、奋力拼搏，向着胜利实现“时间过半、任务过半”的目标全力冲刺。04福建同春福建同春锚定“双过半”目标，以质量管控为基石、以市场开拓为抓手，全面推进各项业务高效运转。福建同春实时跟踪各业务线毛利率变化，加强对应收、应付情况的考核。公司聚焦核心供应商战略协同，全力打造供应商共赢生态圈，截至目前，与供应商合作的多个项目超额完成阶段性目标，进度优于预期。同时，公司深入分析行业趋势和客户需求，制定差异化市场策略，成功引进多项新品。福建同春将进一步聚焦重点项目与核心业务，为全年经营目标达成筑牢根基。当前，南京医药正以“时不我待”的紧迫感和“舍我其谁”的责任感，在冲刺“双过半”的赛道上奋勇前行，全体员工将继续发扬迎难而上的奋斗精神，以更昂扬的斗志和更高效的执行力，朝着既定发展目标稳步迈进。来源：江苏业务中心、安徽天星、南药湖北、福建同春","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2544165777","isCrawlerRequest":true}